FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092013323> ?p ?o ?g. }

• W2092013323 endingPage "643" @default.
• W2092013323 startingPage "626" @default.
• W2092013323 abstract "Degenerative disc disease (DDD) is still a poorly understood phenomenon because of the lack of availability of precise definition of healthy, ageing and degenerated discs. Decreased nutrition is the final common pathway for DDD and the status of the endplate (EP) plays a crucial role in controlling the extent of diffusion, which is the only source of nutrition. The vascular channels in the subchondral plate have muscarinic receptors but the possibility of enhancing diffusion pharmacologically by dilation of these vessels has not been probed. Although it is well accepted that EP damage will affect diffusion and thereby nutrition, there is no described method to quantify the extent of EP damage. Precise definitions with an objective method of differentiating healthy, ageing and degenerated discs on the basis of anatomical integrity of the disc and physiological basis of altered nutrition will be useful. This information is an urgent necessity for better understanding of DDD and also strategizing prevention and treatment. Seven hundred and thirty endplates of 365 lumbar discs from 73 individuals (26 healthy volunteers and 47 patients) with age ranging from 10-64 years were evaluated by pre-contrast and 10 min, 2, 4, 6 and 12 h post contrast MRI after IV injection of 0.3 mmol/kg of Gadodiamide. End plates were classified according to the extent of damage into six grades and an incremental score was given for each category. A total endplate score (TEPS) was derived by adding the EP score of the two endplates for each concerned disc. The base line value (SI(base)) and the signal intensity at particular time periods were used to derive the enhancement percentage for each time period (Enhancement (%) = SI(tp) - SI(base)/SI(base) x 100). The enhancement percentage for each time period, the time for peak enhancement (T-max) and the time intensity curve (TIC) over 12 h were used to study and compare the diffusion characteristics. The differences in pattern of diffusion were obvious visually at 4 h which was categorized into five patterns-Pattern A representing normal diffusion to Pattern E representing a total abnormality in diffusion. Degeneration was classified according to Pfirrmann's grading and this was correlated to the TEPS and the alterations in diffusion patterns. The relationship of TEPS on the increase in DDD was evaluated by a logistic curve and the cut point for severe DDD was found by ROC curve. The influence of the variables of age, level, Modic changes, instability, annulus fibrosis defect (DEBIT), TEPS and diffusion patterns on DDD was analyzed by multiple and stepwise regression analysis. Oral nimodipine study: Additional forty lumbar end-plates from four young healthy volunteers were studied to document the effect of oral nimodipine. Pre-drug diffusion levels were studied by pre and post contrast MRI (0.3 mmol/kg of gadodiamide) at 10 min, 2, 4, 6, 12 and 24 h. Oral nimodipine was administered (30 mg QID) for 5 days and post-contrast MRI studies were performed similarly. Enhancement was calculated at vertebral body-VB; subchondral bone-SCB; Endplate Zone-EPZ and at superior and inferior peripheral nucleus pulposus-PNP and central nucleus pulposus-CNP, using appropriate cursors by a blinded investigator. Paired sample t test and area under curve (AUC) measurements were done.The incidence of disc degeneration had a significant correlation with increasing TEPS (Trend Chi-square, P < 0.01). Only one out of 83 (1.2%) disc had either Pfirrmann Grade IV or V when the score was 4 or below when compared to 34/190 (17.9%) for scores 5-7; 41 of 72 (56.9%) for scores 8-10 and 18 of 20 (90%) for scores 11 and 12 (P < 0.001 for all groups). Pearson's correlation between TEPS and DDD was statistically significant, irrespective of the level of disc or different age groups (r value was above 0.6 and P < 0.01 for all age groups). Logistic curve fit analysis and ROC curve analysis showed that the incidence of DDD increased abruptly when the TEPS crossed six. With a progressive increase of end plate damage, five different patterns of diffusion were visualized. Pattern D and E represented totally altered diffusion pattern questioning the application of biological method of treatment in such situations. Four types of time intensity curves (TIC) were noted which helped to differentiate between healthy, aged and degenerated discs. Multiple and stepwise regression analysis indicated that pattern of disc diffusion and TEPS to be the most significant factors influencing DDD, irrespective of age. Nimodipine increased the average signal intensity for all regions-by 7.6% for VB, 8% for SCB and EPZ and 11% for CNP at all time intervals (P < 0.01 for all cases). Although the increase was high at all time intervals, the maximum increase was at 2 h for VB, SCB and EPZ; 4 h for PNP and 12 h for CNP. It was also interesting that post-nimodipine, the peak signal intensity was attained early, was higher and maintained longer compared to pre-nimodipine values. Our study has helped to establish that EP damage as a crucial event leading to structural failure thereby precipitating DDD. An EP damage score has been devised which had a good correlation to DDD and discs with a score of six and above can be considered 'at risk' for severe DDD. New data on disc diffusion patterns were obtained which may help to differentiate healthy, ageing and degenerated discs in in-vivo conditions. This is also the first study to document an increase in diffusion of human lumbar discs by oral nimodipine and poses interesting possibility of pharmacological enhancement of lumbar disc nutrition." @default.
• W2092013323 created "2016-06-24" @default.
• W2092013323 creator A5008245819 @default.
• W2092013323 creator A5043252953 @default.
• W2092013323 creator A5076291444 @default.
• W2092013323 creator A5087878636 @default.
• W2092013323 creator A5051876346 @default.
• W2092013323 date "2008-03-21" @default.
• W2092013323 modified "2023-10-06" @default.
• W2092013323 title "Pharmacological enhancement of disc diffusion and differentiation of healthy, ageing and degenerated discs" @default.
• W2092013323 cites W143623202 @default.
• W2092013323 cites W1581461985 @default.
• W2092013323 cites W1897804960 @default.
• W2092013323 cites W1964559562 @default.
• W2092013323 cites W1966188170 @default.
• W2092013323 cites W1973004842 @default.
• W2092013323 cites W1973363797 @default.
• W2092013323 cites W1990730164 @default.
• W2092013323 cites W1996917356 @default.
• W2092013323 cites W1997420170 @default.
• W2092013323 cites W1997980872 @default.
• W2092013323 cites W1998384062 @default.
• W2092013323 cites W1999138373 @default.
• W2092013323 cites W2002078337 @default.
• W2092013323 cites W2007590483 @default.
• W2092013323 cites W2011890237 @default.
• W2092013323 cites W2013017205 @default.
• W2092013323 cites W2014256100 @default.
• W2092013323 cites W2017140271 @default.
• W2092013323 cites W2018559769 @default.
• W2092013323 cites W2020612106 @default.
• W2092013323 cites W2022684362 @default.
• W2092013323 cites W2024585159 @default.
• W2092013323 cites W2032518686 @default.
• W2092013323 cites W2033118945 @default.
• W2092013323 cites W2034309273 @default.
• W2092013323 cites W2036906183 @default.
• W2092013323 cites W2037998434 @default.
• W2092013323 cites W2038420290 @default.
• W2092013323 cites W2043645140 @default.
• W2092013323 cites W2050860025 @default.
• W2092013323 cites W2053964636 @default.
• W2092013323 cites W2058667888 @default.
• W2092013323 cites W2060600598 @default.
• W2092013323 cites W2060861339 @default.
• W2092013323 cites W2062712136 @default.
• W2092013323 cites W2063552028 @default.
• W2092013323 cites W2064979257 @default.
• W2092013323 cites W2066108134 @default.
• W2092013323 cites W2067364761 @default.
• W2092013323 cites W2067800125 @default.
• W2092013323 cites W2068030474 @default.
• W2092013323 cites W2069070935 @default.
• W2092013323 cites W2073445487 @default.
• W2092013323 cites W2074206498 @default.
• W2092013323 cites W2076466392 @default.
• W2092013323 cites W2087563256 @default.
• W2092013323 cites W2093434767 @default.
• W2092013323 cites W2094458540 @default.
• W2092013323 cites W2100441031 @default.
• W2092013323 cites W2104960492 @default.
• W2092013323 cites W2107166657 @default.
• W2092013323 cites W2113525055 @default.
• W2092013323 cites W2114460521 @default.
• W2092013323 cites W2129465868 @default.
• W2092013323 cites W2141302405 @default.
• W2092013323 cites W2148905883 @default.
• W2092013323 cites W2152983876 @default.
• W2092013323 cites W2169558926 @default.
• W2092013323 cites W2313767887 @default.
• W2092013323 cites W2320073760 @default.
• W2092013323 cites W2320138524 @default.
• W2092013323 cites W2321662954 @default.
• W2092013323 cites W2323837976 @default.
• W2092013323 cites W2326211238 @default.
• W2092013323 cites W2328082294 @default.
• W2092013323 cites W2329972184 @default.
• W2092013323 cites W2338817155 @default.
• W2092013323 cites W2398791362 @default.
• W2092013323 cites W2406721410 @default.
• W2092013323 cites W4229779917 @default.
• W2092013323 cites W78879306 @default.
• W2092013323 doi "https://doi.org/10.1007/s00586-008-0645-6" @default.
• W2092013323 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2367412" @default.
• W2092013323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18357472" @default.
• W2092013323 hasPublicationYear "2008" @default.
• W2092013323 type Work @default.
• W2092013323 sameAs 2092013323 @default.
• W2092013323 citedByCount "150" @default.
• W2092013323 countsByYear W20920133232012 @default.
• W2092013323 countsByYear W20920133232013 @default.
• W2092013323 countsByYear W20920133232014 @default.
• W2092013323 countsByYear W20920133232015 @default.
• W2092013323 countsByYear W20920133232016 @default.
• W2092013323 countsByYear W20920133232017 @default.
• W2092013323 countsByYear W20920133232018 @default.
• W2092013323 countsByYear W20920133232019 @default.
• W2092013323 countsByYear W20920133232020 @default.

• next